The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -2,315 | -7,869 |
| Bad debt (recovery) expense | 76 | -246 |
| Amortization of debt discount | 123 | 225 |
| Amortization of acquired intangible assets | 1,064 | 2,129 |
| Amortization of operating lease right-of-use assets | 22 | 43 |
| Share-based compensation | 1,854 | 2,659 |
| Accounts receivable | 2,415 | 5,167 |
| Inventory | -1,034 | -1,579 |
| Prepaid expenses and other current assets | -841 | -733 |
| Accounts payable | -1,197 | -3,296 |
| Due to related party | -85 | 312 |
| Accrued expenses | -1,362 | 5,137 |
| Accrued interest | 0 | 12 |
| Income tax payable | 0 | 11 |
| Lease liabilities | -23 | -36 |
| Net cash used in operating activities | -2,383 | -3,774 |
| Proceeds from exercise of stock options | 103 | 240 |
| Proceeds from issuance of common stock, atm offering, net of issuance costs | 6,891 | 4,048 |
| Issuance of common stock under espp | 119 | 99 |
| Payment of debt issuance costs | 75 | - |
| Payments of license installment note payable | 0 | 625 |
| Net cash provided by financing activities | 7,038 | 3,762 |
| Net change in cash | 4,655 | -12 |
| Cash and cash equivalents at beginning of period | 20,305 | - |
| Cash and cash equivalents at end of period | 24,948 | - |
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)